The END Fund

Ellen Agler, the CEO of the END Fund, and Mark Stoleson, the CEO of Legatum, are this episode’s guests. In 2006, Legatum realized that millions of people in Rwanda and Burundi were needlessly suffering from treatable neglected tropical diseases, such as intestinal worms, so it decided to fund programs to address this huge problem. After its work demonstrated the feasibility of scaling these programs, Legatum created the END Fund. As Ellen and Mark discuss, these diseases affect hundreds of millions of people each year in Africa, devastating so many lives, but they are all potentially curable at very little cost per life affected.  To date, the END Fund has already provided over a billion treatments, and it has set the ambitious goal of eliminating these diseases entirely within our lifetimes.  (0:37).

Website:  https://www.end.org/